Phosphomannomutase 2 (PMM2)-congenital disorder of glycosylation (CDG) (previously CDG-Ia; OMIM # 212065) is the most common disorder of protein N-glycosylation in humans, affecting over 1000 patients worldwide (1). This evidence concerns the gene PMM2 and congenital disorder of glycosylation.